Granted Patent
B2
US 12,378,519 · App. 18/529,198 · Granted Aug 5, 2025
Microfluidic model of the blood brain barrier
Inventors:
S. Jordan Kerns (Reading, MA); Norman Wen (West Roxbury, MA); Carolina Lucchesi (Westwood, MA); Christopher David Hinojosa (Cambridge, MA); Jacob Fraser (Somerville, MA); Geraldine Hamilton (Boston, MA); Gad Vatine (Los Angeles, CA); Samuel Sances (Santa Monica, CA); Clive Svendsen (Pacific Palisades, CA); Daniel Levner (Brookline, MA); Dhruv Sareen (Porter Ranch, CA)
C12N5/0619C12N5/0622C12N5/069C12N5/0692C12Q1/02B01L3/5027B01L2200/0647B01L2300/0861C12M23/16C12M25/02C12M35/08C12N5/0618C12N2502/081C12N2502/086C12N2502/28C12N2506/45C12N2531/00C12N2533/52C12N2533/54C12N2533/56C12N2535/10C12N2539/00
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to culturing brain endothelial cells, and optionally astrocytes and neurons in a fluidic device under conditions whereby the cells mimic the structure and function of the blood brain barrier. Culture of such cells in a microfluidic device, whether alone or in combination with other cells, drives maturation and/or differentiation further than existing systems.
Claims (22)
1. A method of culturing cells, comprising:
a) providing a microfluidic device comprising a porous membrane, said membrane comprising a top surface and a bottom surface;
b) seeding brain microvascular endothelial cells on said bottom surface so as to create seeded-cells on said bottom surface of said membrane;
c) seeding stem cell-derived neuronal cells or neuronal cells differentiated from stem cells on said top surface to create seeded cells on said top surface of said membrane; and
d) culturing said top surface seeded cells under flow conditions that support the maturation of neurons and culturing said bottom surface seeded cells under conditions that support maturation of said brain microvascular endothelial cells wherein said neurons exhibit a more mature electrophysiology, in terms of one or more features selected from the group consisting of action potential patterns, negative sodium channel current, positive potassium channel current and action potential spikes of amplitude, duration and frequency, or increased frequency after exposure to said flow as compared to the same neurons cultured in a static culture.
2. The method of claim 1 , further comprising e) seeding astrocytes to create seeded astrocyte cells.
3. The method of claim 2 , further comprising culturing said astrocytes under conditions such that an astrocyte or portion thereof transmigrates said membrane and contacts one or more said brain microvascular endothelial cells on said bottom surface.
4. The method of claim 1 , wherein said stem cell-derived cells are derived or extracted from EZ spheres, iNPCs or iMNPs, and/or wherein said seeded cells in step c) are human cells.
5. A method of culturing cells, comprising:
a) providing a microfluidic device comprising a porous membrane, said membrane comprising a top surface and a bottom surface;
b) coating said top surface of said membrane with laminin and said bottom surface with a mixture of collagen and fibronectin, said mixture free of laminin;
c) seeding induced neural progenitor cells on said top surface and brain microvascular endothelial cells on said bottom surface so as to create seeded cells;
d) exposing said seeded cells to a flow of culture media; and
e) culturing said seeded cells to exhibit a more mature electrophysiology as compared to the same neurons cultured in a static culture.
6. The method of claim 5 , wherein said induced neural progenitor cells are derived from induced pluripotent stem cells from a human patient diagnosed with a central nervous system (CNS) disorder.
7. The method of claim 5 , wherein said flow promotes the differentiation of said induced neural progenitor cells.
8. The method of claim 7 , wherein said induced neural progenitor cells differentiate into neurons.
9. The method of claim 8 , wherein said neurons exhibit a more mature electrophysiology in terms of action potential patterns after exposure to said flow as compared to the same neurons cultured in a static culture.
10. The method of claim 5 , wherein said induced neural progenitor cells are derived from induced pluripotent stem cells from a patient diagnosed with Amyotrophic lateral sclerosis (ALS).
11. The method of claim 5 , wherein said brain microvascular endothelial cells are derived from induced pluripotent stem cells from a patient diagnosed with MCT8-specific thyroid hormone cell-membrane transporter deficiency and/or wherein the seeded cells are cultured such that said brain microvascular endothelial cells on said bottom surface form tight junctions.
12. The method of claim 5 , wherein said induced neural progenitor cells were stored frozen and then thawed prior to step c).
13. The method of claim 5 , wherein said more mature electrophysiology comprises one or more features selected from the group consisting of action potential patterns, negative sodium channel current, positive potassium channel current and action potential spikes of amplitude, duration and frequency that are similar to neurons in a physiological environment, or an increased frequency as compared to the same neurons cultured in a static culture.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 17, 2024
From: KERNS, S JORDAN; WEN, NORMAN; LUCCHESI, CAROLINA; HINOJOSA, CHRISTOPHER DAVID; FRASER, JACOB; HAMILTON, GERALDINE; VATINE, GAD; SANCES, SAMUEL; SVENDSEN, CLIVE; LEVNER, DANIEL; SAREEN, DHRUV
To: EMULATE, INC; CEDARS-SINAI MEDICAL CENTER
Reel/Frame 068013/0050 →
Continuity (6)
Continuation
15768736
Provisional Application
62380780
· Aug 29, 2016
Provisional Application
62332727
· May 6, 2016
Provisional Application
62277723
· Jan 12, 2016
Provisional Application
62243642
· Oct 19, 2015
References Cited (162)
US 8647861B2
· Ingber et al.
· 2014
[cited by applicant]
US 9034571B2
· Berry et al.
· 2015
[cited by applicant]
US 20070077649A1
· Sammak et al.
· 2007
[cited by applicant]
US 20080044847A1
· Shusta
· 2008
[cited by examiner]
US 20120211373A1
· El-Sayed et al.
· 2012
[cited by applicant]
US 20120282682A1
· Walsh et al.
· 2012
[cited by applicant]
US 20130029419A1
· Shusta et al.
· 2013
[cited by applicant]
US 20140093905A1
· Ingber et al.
· 2014
[cited by applicant]
US 20150023911A1
· Schilling et al.
· 2015
[cited by applicant]
US 20150079584A1
· Gevaert et al.
· 2015
[cited by applicant]
US 20150087004A1
· Chen et al.
· 2015
[cited by applicant]
WO WO1994016059
· 1994
[cited by applicant]
WO WO2010009307
· 2010
[cited by applicant]
WO WO2012118799
· 2012
[cited by applicant]
WO WO2013086486
· 2013
[cited by applicant]
WO WO2013086502
· 2013
[cited by applicant]
WO WO2014210364
· 2014
[cited by applicant]
WO WO2015013332
· 2015
[cited by applicant]
WO WO2015138032
· 2015
[cited by applicant]
WO WO2015138034
· 2015
[cited by applicant]
WO WO2015138032A2
· 2015
[cited by examiner]
WO WO2017035119
· 2017
[cited by applicant]
WO WO2019178251
· 2019
[cited by applicant]
WO WO2020198693
· 2020
[cited by applicant]
Kerns et al., U.S. Appl. No. 15/768,736; Apr. 16, 2018.
[cited by examiner]
Kerns et al., U.S. Appl. No. 15/352,289; Nov. 15, 2016.
[cited by examiner]
Abbott, N. J. et al. (2010) “Structure and function of the blood-brain barrier,”
[cited by applicant]
Abbott, N. J. et al. (2006) “Astrocyte-endothelial interactions at the blood-brain barrier,”
[cited by applicant]
Achyuta, A. K. et al. (2013) “A modular approach to create a neurovascular unit-on-a-chip,”
[cited by applicant]
Adriani, G. et al. (2015) “Modeling the Blood-Brain Barrier in a 3D triple co-culture microfluidic system,”
[cited by applicant]
Alcendor, D. J. et al. (2012) “Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus,”
[cited by applicant]
Aloisi, F. et al. (1992) “Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha,”
[cited by applicant]
Annabi, N. et al. (2010) “Controlling the porosity and microarchitecture of hydrogels for tissue engineering,”
[cited by applicant]
Armulik, A. et al. (2010) “Pericytes regulate the blood-brain barrier,”
[cited by applicant]
Bell, R. D. et al. (2009) “Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease,”
[cited by applicant]
Bischel, L. L. et al. (2012) “A Practical Method for Patterning Lumens through ECM Hydrogels via Viscous Finger Patterning,”
[cited by applicant]
Bischel, L. L. et al. (2013) “Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels,”
[cited by applicant]
Booth, R. et al. (2012) “Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB),”
[cited by applicant]
Booth, R. et al. (2014) “Permeability Analysis of Neuroactive Drugs Through a Dynamic Microfluidic In Vitro Blood-Brain Barrier Model,”
[cited by applicant]
Booth, R. H. (2014) A Microfluidic in Vitro Model of the Blood-Brain Barrier, in
[cited by applicant]
Brown, J. A. et al. (2015) “Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor,”
[cited by applicant]
Cashman, C. R. et al. (2013) “Induced Pluripotent Stem Cells and Motor Neuron Disease: Toward an Era of Individualized Medicine.”
[cited by applicant]
Cecchelli, R. et al. (2007) “Modelling of the blood-brain barrier in drug discovery and development,”
[cited by applicant]
Chaudhuri, A. et al. (2008) “HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction,”
[cited by applicant]
Cho, H. et al. (2015) “Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology.”
[cited by applicant]
Choi, S. S. et al. (2014) “Human astrocytes: secretome profiles of cytokines and chemokines,”
[cited by applicant]
Corps, K. N. et al. (2015) “Inflammation and neuroprotection in traumatic brain injury,”
[cited by applicant]
Cucullo, L. et al. (2008) “Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies,”
[cited by applicant]
Cucullo, L. et al. (2011) “The role of shear stress in Blood-Brain Barrier endothelial physiology,”
[cited by applicant]
Cucullo, L. et al. (2013) “A new dynamic in vitro modular capillaries-venules modular system: Cerebrovascular physiology in a box.”
[cited by applicant]
Cucullo, L. et al. (2002) “A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier,”
[cited by applicant]
Davis, G. E. et al. (2005) “Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.”
[cited by applicant]
Deli, M. A. et al. (2005) “Permeability Studies on In Vitro Blood-Brain Barrier Models:Physiology, Pathology, and Pharmacology,”
[cited by applicant]
Deli, M. A. et al. (1995) “Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic st…
[cited by applicant]
Deosarkar, S. P. et al. (2015) “A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip,”
[cited by applicant]
Dhumpa, R. et al. (2012) “Temporal gradients in microfluidic systems to probe cellular dynamics: a review,” Analytica Chimica Acta 743, 9-18.
[cited by applicant]
Dimos, J. T. et al. (2008) “Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons,”
[cited by applicant]
Dong, B. et al. (2010) “Lattice Boltzmann simulation of viscous fingering phenomenon of immiscible fluids displacement in a channel.”
[cited by applicant]
Douville, N. J. et al. (2010) “Fabrication of Two-Layered Channel System with Embedded Electrodes to Measure Resistance Across Epithelial and Endothelial Barriers,” Analytical Chemistry 82(6), 2505-2511.
[cited by applicant]
Ebert, A. D. et al. (2013) “EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs,”
[cited by applicant]
Erta, M. et al. (2012) “Interleukin-6, a major cytokine in the central nervous system,”
[cited by applicant]
Farina, C et al. (2007) “Astrocytes are active players in cerebral innate immunity,”
[cited by applicant]
Fee, D. et al. (2000) “Interleukin 6 Promotes Vasculogenesis of Murine Brain Microvessel Endothelial Cells,”
[cited by applicant]
Förster, C. et al. (2008) “Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier,”
[cited by applicant]
Gaillard, P. J et al. (2001) “Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes,”
[cited by applicant]
Gibson, C. L. et al. (2005) “G-CSF reduces infarct vol. and improves functional outcome after transient focal cerebral ischemia in mice,”
[cited by applicant]
Griep, L. M. et al. (2013) “BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function,”
[cited by applicant]
Gross, P. G et al. (2007) “Applications of microfluidics for neuronal studies,”
[cited by applicant]
Hasan, A. et al. (2015) “A multilayered microfluidic blood vessel-like structure,”
[cited by applicant]
Hauser, S. L. et al. (2006) “The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration,”
[cited by applicant]
Hawkins, B. T. et al. (2005) “The Blood-Brain Barrier/Neurovascular Unit in Health and Disease,”
[cited by applicant]
Herland, A. et al. (2016) “Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip,”
[cited by applicant]
Hofman, F. M. et al. (1999) “HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells,”
[cited by applicant]
Huxley, V. H. et al. (1987) “Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport,”
[cited by applicant]
Jansson, D. et al. (2014) “A role for human brain pericytes in neuroinflammation,”
[cited by applicant]
Jones, S. A. (2005) “Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6,”
[cited by applicant]
Kang, Q. et al. (2004) “Immiscible displacement in a channel: simulations of fingering in two dimensions,”
[cited by applicant]
Kelamangalath, L. et al. (2011) “K-Opioid Receptor Inhibition of Calcium Oscillations in Spinal Cord Neurons,”
[cited by applicant]
Kim, D. et al. (2013) “Protein immobilization techniques for microfluidic assays,”
[cited by applicant]
Kim, J. A. et al. (2015) “Collagen-based brain microvasculature model in vitro using three-dimensional printed template,”
[cited by applicant]
Kong, D. et al. (2004) “Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries,”
[cited by applicant]
Kossmann, T. et al. (1997) “Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production,”
[cited by applicant]
Kovac, A. et al. (2011) “Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide,”
[cited by applicant]
Kuo, Y.-C. et al. (2011) “Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier,”
[cited by applicant]
Liebner, S. et al. (2011) “Current concepts of blood-brain barrier development,”
[cited by applicant]
Lin, H. J. et al. (2004) “Neural stem cell differentiation in a cell-collagen-bioreactor culture system,”
[cited by applicant]
Lippmann, E. S. et al. (2014) “A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources,”
[cited by applicant]
Lippmann, E. S. et al. (2013) “Modeling the blood-brain barrier using stem cell sources,”
[cited by applicant]
Lippmann, E. S. et al. (2012) “Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells,”
[cited by applicant]
Mabondzo, A. et al. (2010) “Validation of In Vitro Cell-Based Human Blood-Brain Barrier Model Using Clinical Positron Emission Tomography Radioligands to Predict In Vivo Human Brain Penetration,”
[cited by applicant]
Minagar, A. et al. (2003) “Blood-brain barrier disruption in multiple sclerosis,”
[cited by applicant]
Moya, M. L. et al. (2013) “In vitro perfused human capillary networks,”
[cited by applicant]
Naik, P. et al. (2012) “<em>In Vitro</em> Blood–Brain Barrier Models: Current and Perspective Technologies,”
[cited by applicant]
Nakagawa, S. et al. (2009) “A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes,”
[cited by applicant]
Nakagawa, S. et al. (2007) “Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells,”
[cited by applicant]
Nehme, A. et al. (2008) “Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes,”
[cited by applicant]
Niego, B. e et al. (2013) “Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier,”
[cited by applicant]
Okita, K et al. (2011) “A more efficient method to generate integration-free human iPS cells,”
[cited by applicant]
Park, J. H. et al. (2010) “Microporous cell-laden hydrogels for engineered tissue constructs,”
[cited by applicant]
Penkowa, M. et al. (2000) “Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice,”
[cited by applicant]
Prabhakarpandian, B. et al. (2013) “SyM-BBB: a microfluidic Blood Brain Barrier model,”
[cited by applicant]
Probert, L. (2015) “TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects,”
[cited by applicant]
Roberts, L. M. et al. (2008) “Expression of the Thyroid Hormone Transporters Monocarboxylate Transporter-8 (SLC16A2) and Organic Ion Transporter-14 (SLCO1C1) at the Blood-Brain Barrier,”
[cited by applicant]
Rosenberg, S. S. et al. (2011) “Calcium Signaling in Neuronal Development,”
[cited by applicant]
Santaguida, S. et al. (2006) “Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study,” Brain research 1109(1), 1-13.
[cited by applicant]
Sareen, D. et al. (2014) “Human neural progenitor cells generated from induced pluripotent stem cells can survive, migrate, and integrate in the rodent spinal cord,”
[cited by applicant]
Sareen, D. et al. (2013) “Targeting RNA foci in iPSC-derived motor neurons from ALS patients with C9ORF72 repeat expansion,”
[cited by applicant]
Schäbitz, W. R. et al. (2003) “Neuroprotective Effect of Granulocyte Colony-Stimulating Factor After Focal Cerebral Ischemia,”
[cited by applicant]
Schneider, A. et al. (2005) “The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis,”
[cited by applicant]
Schwartz, C. E. et al. (2005) “Allan-Herndon-Dudley Syndrome and the Monocarboxylate Transporter 8 (MCT8) Gene,”
[cited by applicant]
Sellgren, K. L. et al. (2015) “An optically transparent membrane supports shear stress studies in a three-dimensional microfluidic neurovascular unit model,”
[cited by applicant]
Semple, B. D. et al. (2010) “Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury,”
[cited by applicant]
Shibata, K. et al. (2007) Collagen micro flow channel for in vitro Blood-Brain Barrier model, in
[cited by applicant]
Song, J. W. et al. (2011) “Fluid forces control endothelial sprouting,”
[cited by applicant]
Swartz, K. R. et al. (2001) “Interleukin-6 promotes post-traumatic healing in the central nervous system,”
[cited by applicant]
Sweeney, M. D. et al. (2018) “Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders,”
[cited by applicant]
Syvänen, S. et al. (2009) “Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport,”
[cited by applicant]
Tarkowski, E. et al. (1995) “Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke,”
[cited by applicant]
Telias, M. et al. (2014) “Electrical maturation of neurons derived from human embryonic stem cells,”
[cited by applicant]
Thangawng, A. L. et al. (2007) “An ultra-thin PDMS membrane as a bio/micro-nano interface: fabrication and characterization,”
[cited by applicant]
Thomsen, L. B. et al. (2015) “A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes,”
[cited by applicant]
Trickler, W. J. et al. (2014) “Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles,”
[cited by applicant]
Urich, E. et al. (2013) “Multicellular self-assembled spheroidal model of the blood brain barrier,”
[cited by applicant]
Van Der Helm, M. W. et al. (2016) “Microfluidic organ-on-chip technology for blood-brain barrier research,”
[cited by applicant]
Van Der Meer, A. et al. (2015) “Blood-brain Barrier (BBB): An overview of the research of the blood-brain barrier using microfluidic devices,”
[cited by applicant]
Van Der Meer, A. D. et al. (2013) “Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device,”
[cited by applicant]
Van Dommelen, J. A. W. et al. (2010) “Mechanical properties of brain tissue by indentation: Interregional variation,”
[cited by applicant]
Vatine, G. D. et al. (2019) “Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications (Supplemental),”
[cited by applicant]
Vatine, G. D. et al. (2019) “Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications,”
[cited by applicant]
Veszelka, S. et al. (2007) “Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages,”
[cited by applicant]
Villa, P. et al. (2007) “The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats,”
[cited by applicant]
Walter, F. R. et al. (2016) “A versatile lab-on-a-chip tool for modeling biological barriers,”
[cited by applicant]
Wang, A. et al. (2020) “Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan-Herndon-Dudley syndrome,”
[cited by applicant]
Warren, M. S. et al. (2009) “Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human,” Pharmacological Research 59(6), 404-413.
[cited by applicant]
Weksler, B. B. et al. (2005) “Blood-brain barrier-specific properties of a human adult brain endothelial cell line,”
[cited by applicant]
Whitesides, G. M. et al. (2001) “Soft Lithography in Biology and Biochemistry,”
[cited by applicant]
wikipedia.com. Gel—Wikipedia (https://en.wikipedia.org/wiki/Gel).
[cited by applicant]
Wolburg, H. et al. (2003) “Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme,”
[cited by applicant]
Wyss-Coray, T. (2006) “Inflammation in Alzheimer disease: driving force, bystander or beneficial response?,”
[cited by applicant]
Xiao, B.-G. et al. (2007) “Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection,”
[cited by applicant]
Yamamoto, K et al. (2005) “Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro,” American Journal of Physiology-Heart and Circulatory Physiology 288…
[cited by applicant]
Yeon, J. H et al. (2012) “Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures,”
[cited by applicant]
Yeon, J. H. et al. (2012) “In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices,”
[cited by applicant]
Yousefzadeh-Chabok, S. et al. (2015) The Relationship Between Serum Levels of Interleukins 6, 8, 10 and Clinical Outcome in Patients With Severe Traumatic Brain Injury, in
[cited by applicant]
Yuan, W. et al. (2009) “Non-invasive measurement of solute permeability in cerebral microvessels of the rat,”
[cited by applicant]
Zilio, C. et al. (2014) “Erratum to: Universal hydrophilic coating of thermoplastic polymers currently used in microfluidics,”
[cited by applicant]
Zsebo, K. M. et al. (1988) “Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF,”
[cited by applicant]
PCT Written Opinion in corresponding International Application No. PCT/US2016/029164 dated Feb. 7, 2017.
[cited by applicant]
PCT International Search Report of International Application No. PCT/US2016/029164 dated Feb. 7, 2017.
[cited by applicant]
European Search Report for Application No. 16858141.1 dated Mar. 15, 2019.
[cited by applicant]
PCT International Search Report of International Application No. PCT/US2016/057724 dated Jan. 9, 2017.
[cited by applicant]